In a clinical study, the 5-year survival rate of cervical cancer patients with high CD4+/ CD8+ ratio was higher than that of patients with low CD4+/ CD8+ ratio, increasing the CD4+/ CD8+ ratio can slow the progression of cervical cancer and improve its prognosis [26]. The gene discussed is CD8A; the disease is cervical carcinoma.